Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 88,825 shares at $61.92 ($5.2M) on 2019-04-16, disclosed to the SEC on 2019-04-16.
Open-market sale of $5.2M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.92 | 38,825 | $2.1M | 40.3% |
| 2 | $61.92 | 50,000 | $3.1M | 59.7% |
| Total | $58.42 avg | 88,825 | $5.2M | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |